267 related articles for article (PubMed ID: 19148486)
1. Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity--evaluation of a new, fully automated non-radiometric assay.
Von Euler HP; Rivera P; Aronsson AC; Bengtsson C; Hansson LO; Eriksson SK
Int J Oncol; 2009 Feb; 34(2):505-10. PubMed ID: 19148486
[TBL] [Abstract][Full Text] [Related]
2. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
von Euler HP; Ohrvik AB; Eriksson SK
Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
[TBL] [Abstract][Full Text] [Related]
3. A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma.
Sharif H; von Euler H; Westberg S; He E; Wang L; Eriksson S
Vet J; 2012 Oct; 194(1):40-7. PubMed ID: 22516918
[TBL] [Abstract][Full Text] [Related]
4. Thymidine kinase assay in canine lymphoma.
Elliott JW; Cripps P; Blackwood L
Vet Comp Oncol; 2013 Mar; 11(1):1-13. PubMed ID: 22236202
[TBL] [Abstract][Full Text] [Related]
5. A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.
Jagarlamudi KK; Moreau L; Westberg S; Rönnberg H; Eriksson S
PLoS One; 2015; 10(9):e0137871. PubMed ID: 26366881
[TBL] [Abstract][Full Text] [Related]
6. Thymidine kinase (TK) activity as a prognostic parameter of survival in lymphoma patients.
Bogni A; Cortinois A; Grasselli G; Seregni E; Crippa F; Castellani MR; Bombardieri E
J Biol Regul Homeost Agents; 1994; 8(4):121-5. PubMed ID: 7660854
[TBL] [Abstract][Full Text] [Related]
7. Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma.
Poley S; Stieber P; Nüssler V; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):3025-9. PubMed ID: 9329592
[TBL] [Abstract][Full Text] [Related]
8. [Serum deoxythymidine kinase in hematological malignancy].
Naito K; Yamada K
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3221-6. PubMed ID: 3196040
[TBL] [Abstract][Full Text] [Related]
9. Changes of serum thymidine kinase in children with acute leukemia.
Votava T; Topolcan O; Holubec L; Cerna Z; Sasek L; Finek J; Kormunda S
Anticancer Res; 2007; 27(4A):1925-8. PubMed ID: 17649797
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of mitoxantrone for the treatment of lymphoma in dogs.
Moore AS; Ogilvie GK; Ruslander D; Rand WS; Cotter SM; Getzy DM; L'Heureux DA; Dennis RA
J Am Vet Med Assoc; 1994 Jun; 204(12):1903-5. PubMed ID: 8077132
[TBL] [Abstract][Full Text] [Related]
11. An in-house assay for serum deoxythymidine kinase.
Seah LH; Ton SH; Cheong SK; Hamidah NH
Malays J Pathol; 1991 Dec; 13(2):109-13. PubMed ID: 1823092
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of mitoxantrone against various neoplasms in dogs.
Ogilvie GK; Obradovich JE; Elmslie RE; Vail DM; Moore AS; Straw RC; Dickinson K; Cooper MF; Withrow SJ
J Am Vet Med Assoc; 1991 May; 198(9):1618-21. PubMed ID: 2061177
[TBL] [Abstract][Full Text] [Related]
13. [Serum deoxythymidine kinase activity in adult T-cell leukemia].
Kagimoto T; Oda T; Nakakuma H; Kawaguchi T; Hidaka M; Horikawa K; Matsuzaki H; Takatsuki K
Gan To Kagaku Ryoho; 1991 Jan; 18(1):63-7. PubMed ID: 1987901
[TBL] [Abstract][Full Text] [Related]
14. High-mobility group B1 proteins in canine lymphoma: prognostic value of initial and sequential serum levels in treatment outcome following combination chemotherapy.
Meyer A; Eberle N; Bullerdiek J; Nolte I; Simon D
Vet Comp Oncol; 2010 Jun; 8(2):127-37. PubMed ID: 20579326
[TBL] [Abstract][Full Text] [Related]
15. Phase II evaluation of doxorubicin for treatment of various canine neoplasms.
Ogilvie GK; Reynolds HA; Richardson RC; Withrow SJ; Norris AM; Henderson RA; Klausner JS; Fowler JD; McCaw D
J Am Vet Med Assoc; 1989 Dec; 195(11):1580-3. PubMed ID: 2599941
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathologic study of canine lymphoma: clinical staging, cell classification, and therapy.
Squire RA; Bush M; Melby EC; Neeley LM; Yarbrough B
J Natl Cancer Inst; 1973 Aug; 51(2):565-74. PubMed ID: 4765373
[No Abstract] [Full Text] [Related]
17. Principles of treatment for canine lymphoma.
Ettinger SN
Clin Tech Small Anim Pract; 2003 May; 18(2):92-7. PubMed ID: 12831068
[TBL] [Abstract][Full Text] [Related]
18. Detection and clinical significance of plasma glutathione-S-transferases in dogs with lymphoma.
Hahn KA; Barnhill MA; Freeman KP; Shoieb AM
In Vivo; 1999; 13(2):173-5. PubMed ID: 10363174
[TBL] [Abstract][Full Text] [Related]
19. Plasma thymidine kinase activity in dogs with lymphoma and leukemia.
Nakamura N; Momoi Y; Watari T; Yoshino T; Tsujimoto H; Hasegawa A
J Vet Med Sci; 1997 Oct; 59(10):957-60. PubMed ID: 9362053
[TBL] [Abstract][Full Text] [Related]
20. Prognostic importance of thymidine kinase in colorectal and breast cancer.
Svobodova S; Topolcan O; Holubec L; Treska V; Sutnar A; Rupert K; Kormunda S; Rousarova M; Finek J
Anticancer Res; 2007; 27(4A):1907-9. PubMed ID: 17649793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
